Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | proteasome subunit beta type 2 | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | proteasome subunit beta type 1 | 0.0087 | 0.1527 | 0.1527 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0444 | 1 | 1 |
Trypanosoma cruzi | proteasome alpha 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | ATP-dependent protease subunit HslV, putative | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome alpha 5 subunit, putative,20S proteasome subunit alpha 5, (putative) | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | hypothetical protein | 0.0276 | 0.601 | 0.601 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0087 | 0.1527 | 0.1194 |
Trypanosoma brucei | proteasome subunit beta type-2, putative | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | proteasome subunit alpha type 7-1 | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome subunit alpha type-5, putative | 0.0038 | 0.0378 | 0.0378 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0444 | 1 | 1 |
Brugia malayi | proteasome subunit alpha type 2 | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | 20s proteasome beta 7 subunit, (putative) | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | proteasome subunit alpha type 3 | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0444 | 1 | 1 |
Trypanosoma cruzi | hslVU complex proteolytic subunit, threonine peptidase, Clan T(1), family T1B | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | 20S proteasome subunit | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | 20s proteasome beta 7 subunit, (putative) | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome alpha 1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome subunit alpha type-1, putative | 0.0038 | 0.0378 | 0.0378 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent protease peptidase subunit | 0.0038 | 0.0378 | 0.5 |
Giardia lamblia | Proteasome subunit beta type 1 | 0.0087 | 0.1527 | 0.1194 |
Leishmania major | 20s proteasome beta 7 subunit, (putative) | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome subunit alpha type-5, putative | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | hs1vu complex proteolytic subunit-like,hs1vu complex proteolytic subunit-like, threonine peptidase, Clan T(1), family T1B | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | 20s proteasome beta 7 subunit, (putative) | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0087 | 0.1527 | 0.1527 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome alpha 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0444 | 1 | 1 |
Trypanosoma brucei | Proteasome subunit A N-terminal signature/Proteasome subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Entamoeba histolytica | proteasome subunit beta type 1, putative | 0.0087 | 0.1527 | 0.1194 |
Trypanosoma brucei | proteasome alpha 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Toxoplasma gondii | proteasome subunit beta type 1, putative | 0.0087 | 0.1527 | 0.1194 |
Leishmania major | proteasome alpha 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome beta-1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta-1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome beta-1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.027 | 0.5875 | 0.5875 |
Trypanosoma brucei | proteasome beta 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | 20s proteasome beta 7 subunit, (putative) | 0.0038 | 0.0378 | 0.0378 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0444 | 1 | 1 |
Leishmania major | proteasome alpha 1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | PAS-3 protein | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | proteasome subunit alpha type 3 | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | Proteasome subunit alpha type 1 | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | proteasome subunit alpha type 1 | 0.0038 | 0.0378 | 0.0378 |
Plasmodium falciparum | proteasome subunit beta type-1, putative | 0.0087 | 0.1527 | 0.1194 |
Loa Loa (eye worm) | hypothetical protein | 0.0276 | 0.601 | 0.601 |
Leishmania major | proteasome alpha 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Schistosoma mansoni | hypothetical protein | 0.0056 | 0.0799 | 0.0438 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0038 | 0.0378 | 0.0378 |
Echinococcus granulosus | proteasome prosome macropain | 0.0444 | 1 | 1 |
Loa Loa (eye worm) | proteasome subunit beta type 3 | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative | 0.0087 | 0.1527 | 0.1527 |
Mycobacterium ulcerans | proteasome PrcB | 0.0444 | 1 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0444 | 1 | 1 |
Trypanosoma cruzi | proteasome alpha 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | proteasome subunit alpha type 6 | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome beta 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | proteasome subunit alpha type 1 | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0444 | 1 | 1 |
Brugia malayi | proteasome subunit alpha type 4 | 0.0038 | 0.0378 | 0.0378 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0444 | 1 | 1 |
Trypanosoma cruzi | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome beta 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Schistosoma mansoni | proteasome subunit beta 1 (T01 family) | 0.0087 | 0.1527 | 0.1194 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0444 | 1 | 1 |
Trypanosoma brucei | ATP-dependent protease subunit HslV | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | 20S proteasome alpha5 subunit | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta-1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome alpha 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | Proteasome subunit alpha type 7-1 | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0444 | 1 | 1 |
Loa Loa (eye worm) | proteasome subunit alpha type 2 | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome alpha 1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Mycobacterium ulcerans | proteasome PrcA | 0.0038 | 0.0378 | 0.0378 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0087 | 0.1527 | 0.1194 |
Leishmania major | proteasome beta 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | 20s proteasome beta 7 subunit, (putative) | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0087 | 0.1527 | 0.1527 |
Trypanosoma cruzi | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome subunit alpha type-5, putative | 0.0038 | 0.0378 | 0.0378 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0276 | 0.601 | 0.5853 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome alpha 1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome beta 6 subunit | 0.0087 | 0.1527 | 0.1527 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0444 | 1 | 1 |
Plasmodium vivax | proteasome subunit beta type-1, putative | 0.0087 | 0.1527 | 0.1194 |
Loa Loa (eye worm) | proteasome subunit beta type 2 | 0.0038 | 0.0378 | 0.0378 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0444 | 1 | 1 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0444 | 1 | 1 |
Trypanosoma brucei | proteasome beta 7 subunit | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma brucei | proteasome alpha 7 subunit | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome alpha 1 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0444 | 1 | 1 |
Trypanosoma cruzi | proteasome alpha 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | follicle stimulating hormone receptor | 0.027 | 0.5875 | 0.5875 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0087 | 0.1527 | 0.1194 |
Loa Loa (eye worm) | proteasome subunit alpha type 6 | 0.0038 | 0.0378 | 0.0378 |
Leishmania major | proteasome beta 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0444 | 1 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0276 | 0.601 | 0.5853 |
Schistosoma mansoni | survival motor neuron protein | 0.0056 | 0.0799 | 0.0438 |
Leishmania major | proteasome beta 3 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Onchocerca volvulus | 0.0056 | 0.0799 | 1 | |
Brugia malayi | 20S proteasome alpha5 subunit | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome alpha 7 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome beta 2 subunit, putative | 0.0038 | 0.0378 | 0.0378 |
Brugia malayi | proteasome subunit beta type 3 | 0.0038 | 0.0378 | 0.0378 |
Trypanosoma cruzi | proteasome subunit beta type-2, putative | 0.0038 | 0.0378 | 0.0378 |
Loa Loa (eye worm) | proteasome subunit beta type 1 | 0.0087 | 0.1527 | 0.1527 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0056 | 0.0799 | 0.0799 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | Neurotoxicity against Mus musculus albino (mouse) at 3 mg/kg, ip after 30 min by rotarod test | ChEMBL. | No reference | |
Activity (ADMET) | = 0 % | Neurotoxicity against Mus musculus albino (mouse) assessed as inability to climb horizontal screen at 3 mg/kg, ip after 30 min by horizontal screen test relative to control | ChEMBL. | No reference |
Activity (ADMET) | = 0 % | Neurotoxicity against Mus musculus albino (mouse) assessed as fall from horizontal screen at 3 mg/kg, ip after 30 min by horizontal screen test relative to control | ChEMBL. | No reference |
Activity (functional) | = 50 % | Antipsychotic activity in Mus musculus albino (mouse) assessed as ptosis at 3 mg/kg, ip relative to control | ChEMBL. | No reference |
Inhibition (functional) | Anticonvulsant activity in Mus musculus albino (mouse) assessed as inhibition of PTZ-induced seizure at 3 mg/kg, ip administered 1 hr prior to PTZ-challenge measured after 2 to 4 min relative to control | ChEMBL. | No reference | |
TIME (functional) | = 125 s | CNS depressant activity in Mus musculus albino (mouse) assessed as immobility time at 3 mg/kg, ip measured after 24 hr by forced swim test (Rvb = 120 +/- 5.1 secs) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.